Shanghai INT Medical Instruments Co (HKSE:01501) COGS-to-Revenue : 0.42 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co COGS-to-Revenue?

Shanghai INT Medical Instruments Co's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$191.8 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$451.8 Mil.

Shanghai INT Medical Instruments Co's COGS to Revenue for the six months ended in Dec. 2023 was 0.42.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shanghai INT Medical Instruments Co's Gross Margin % for the six months ended in Dec. 2023 was 57.55%.

Shanghai INT Medical Instruments Co COGS-to-Revenue Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co COGS-to-Revenue Chart

Shanghai INT Medical Instruments Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.39

0.35

0.41

0.43

0.42

Shanghai INT Medical Instruments Co Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial								0.44	0.45	0.42	0.41	0.42

Shanghai INT Medical Instruments Co COGS-to-Revenue Calculation

Shanghai INT Medical Instruments Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	344.284	/	823.436
	=	0.42

Shanghai INT Medical Instruments Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	191.796	/	451.809
	=	0.42

Shanghai INT Medical Instruments Co (HKSE:01501) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shanghai INT Medical Instruments Co's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	191.796 / 451.809
	=	57.55 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Shanghai INT Medical Instruments Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.kdl-int.com

Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Executives

China Orient Asset Management (international) Holding Limited	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Zhao Wei	2202 Interest of your spouse
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Health Investment Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership)	2101 Beneficial owner
Wang Kai	2201 Interest of corporation controlled by you
Zhao Wei	2202 Interest of your spouse
Shanghai Gongye Investment Co., Ltd.	2201 Interest of corporation controlled by you
Zhang Wei	2501 Other
Worldwide Healthcare Trust Plc	2101 Beneficial owner
Orbimed Capital Llc	2102 Investment manager
Zheng Aiping	2501 Other
Zhang Xianmiao	2501 Other
Zhang Wei	2501 Other

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines